Trump's visit to the UK received "generous gift": GSK promises to invest $300 billion in the US.

According to the Securities Times APP, British pharmaceutical giant GlaxoSmithKline (GSK.US) has pledged to invest $30 billion in the United States over the next five years. The announcement comes as US President Trump arrives in the UK for a highly anticipated state visit.